Traditional testing methods for monoclonal protein in Plasma Cell Dyscrasias correctly identify a majority of patients. However, limitations in these methods can cause patients to be missed at ...
Current standard modalities for detecting and quantifying monoclonal immunoglobin in patients with cold agglutinin disease lack adequate sensitivity. Heavy chain/light chain assay may be more ...
In a recent study published in the journal Nature, researchers investigate whether pairs of unrelated B-cells of naive, unswitched, memory and plasmablast phenotypes that have similar heavy chains ...
Lonza’s bYlok® technology is changing the way bispecific antibodies are designed. Achieving the correct heterodimerization of light and heavy chains during bispecific production can be challenging, ...
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today officially launched its fully human heavy chain antibody platform, RenNano™. RenNano™ is the ...
Okay, this is gonna sound complicated at first, but bear with me and let’s see if we can’t make it a bit easier… So, a diagnosis of multiple myeloma usual involves a blood test known as a “Serum Free ...
Company will combine mouse tech with YAC platform to generate human heavy chain drugs. U.K.-based Crescendo Biologics says it has developed a colony of triple-knockout mice that are totally lacking in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback